Inventor · disambiguated record
Ming-Shi Chang
Also filed as: CHANG MING S · CHANG MING-SHI
42 granted patents·12 pending applications·864 citations·filing 1990–2020
98Inventor score
Top patents by PatentIndex Score
54 records- 0196US6015938AOsteoprotegerinAMGEN INC·Filed 1997·Granted Jan 18, 2000·158 cites·2 claims
- 0295US8377441B2Treating breast cancer with anti-IL-19 antibodyUNIV NAT CHENG KUNG·Filed 2010·Granted Feb 19, 2013·15 cites·21 claims
- 0395US7611705B2Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseasesUNIV NAT CHENG KUNG·Filed 2007·Granted Nov 3, 2009·33 cites·8 claims
- 0495US6284485B1Nucleic acids encoding osteoprotegerinAMGEN INC·Filed 1997·Granted Sep 4, 2001·123 cites·16 claims
- 0594US8603470B1Use of IL-20 antagonists for treating liver diseasesCHANG MING-SHI·Filed 2012·Granted Dec 10, 2013·13 cites·11 claims
- 0694US7435800B2Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferationCHI MEI MEDICAL CT·Filed 2006·Granted Oct 14, 2008·31 cites·1 claims
- 0792US8454956B2Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodiesCHANG MING-SHI·Filed 2010·Granted Jun 4, 2013·8 cites·13 claims
- 0892US8206712B2Use of anti-IL-20 antibody for treating rheumatoid arthritisCHANG MING-SHI·Filed 2010·Granted Jun 26, 2012·8 cites·16 claims
- 0991US8012478B2Use of anti-IL-20 antibody for treating strokeUNIV NAT CHENG KUNG·Filed 2008·Granted Sep 6, 2011·13 cites·6 claims
- 1091US7837994B2Use of anti-IL-20 antibody for treating osteoporosisUNIV NAT CHENG KUNG·Filed 2008·Granted Nov 23, 2010·16 cites·12 claims
- 1191US6288032B1OsteoprotegerinAMGEN INC·Filed 1997·Granted Sep 11, 2001·56 cites·14 claims
- 1290US8597647B1Humanized anti-IL-20 antibody and uses thereofCHANG MING-SHI·Filed 2012·Granted Dec 3, 2013·12 cites·15 claims
- 1390US7786274B2Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseasesUNIV NAT CHENG KUNG·Filed 2008·Granted Aug 31, 2010·12 cites·4 claims
- 1490US6284728B1OsteoprotegerinAMGEN INC·Filed 1997·Granted Sep 4, 2001·57 cites·9 claims
- 1590US6284740B1OsteoprotegerinAMGEN INC·Filed 1997·Granted Sep 4, 2001·56 cites·20 claims
- 1686US8344110B2Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereofAMGEN INC·Filed 2011·Granted Jan 1, 2013·10 cites·9 claims
- 1786US6369027B1OsteoprotegerinAMGEN INC·Filed 1996·Granted Apr 9, 2002·65 cites·19 claims
- 1885US7005413B1Combination therapy for conditions leading to bone lossAMGEN INC·Filed 2000·Granted Feb 28, 2006·16 cites·15 claims
- 1982US5352587ACompositions and methods for the synthesis of natriuretic protein receptor B and methods of useGENENTECH INC·Filed 1990·Granted Oct 4, 1994·43 cites·21 claims
- 2080USD494716STreat dispensing toyFiled 2003·Granted Aug 17, 2004·31 cites·1 claims
- 2179US6613544B1OsteoprotegerinAMGEN INC·Filed 1995·Granted Sep 2, 2003·20 cites·13 claims
- 2278US8852588B2Treating allergic airway disorders using anti-IL-20 receptor antibodiesCHANG MING-SHI·Filed 2012·Granted Oct 7, 2014·2 cites·16 claims
- 2377US9217031B2Humanized anti-IL-20 antibody and uses thereofUNIV NAT CHENG KUNG·Filed 2013·Granted Dec 22, 2015·2 cites·11 claims
- 2474US9127066B2Methods for treating osteoporosis with anti-IL-20 receptor antibodiesCHANG MING-SHI·Filed 2011·Granted Sep 8, 2015·2 cites·7 claims
- 2574US8535674B2Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibodyCHANG MING-SHI·Filed 2010·Granted Sep 17, 2013·2 cites·22 claims
- 2672US7632922B1OsteoprotegerinAMGEN INC·Filed 2000·Granted Dec 15, 2009·1 cites·11 claims
- 2772US5741772ANeurotrophic factor NNT-1AMGEN INC·Filed 1997·Granted Apr 21, 1998·21 cites·6 claims
- 2870US9221904B2Treatment of osteoarthritis using IL-20 antagonistsUNIV NAT CHENG KUNG·Filed 2013·Granted Dec 29, 2015·1 cites·13 claims
- 2969US8911730B2Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activityAMGEN INC·Filed 2012·Granted Dec 16, 2014·1 cites·6 claims
- 3066US6143874AAntibodies to the neurotrophic factor NNT-1AMGEN INC·Filed 1998·Granted Nov 7, 2000·21 cites·4 claims
- 3163US9365652B2Use of IL-20 antagonists for treating liver diseasesUNIV NAT CHENG KUNG·Filed 2013·Granted Jun 14, 2016·0 cites·9 claims
- 3263US2010298229A1OsteoprotegerinAMGEN INC·Filed 2009·Application pending·0 cites
- 3362US9683036B2Humanized anti-IL-20 antibody and uses thereofUNIV NAT CHENG KUNG·Filed 2013·Granted Jun 20, 2017·0 cites·17 claims
- 3461US7964713B2Nucleic acid molecules encoding thymic stromal lympopoietin receptor proteins and a process for producing the encoded polypeptides thereofAMGEN INC·Filed 2001·Granted Jun 21, 2011·1 cites·13 claims
- 3560US12409208B2Treating tissue fibrosis with interleukin 24LBL BIOTECHNOLOGY INC·Filed 2020·Granted Sep 9, 2025·0 cites·11 claims
- 3660US2005221331A1OsteoprotegerinAMGEN INC·Filed 2004·Application pending·0 cites
- 3759US6054294ANucleic acid molecules encoding the neurotrophic factor NNT-1AMGEN INC·Filed 1997·Granted Apr 25, 2000·14 cites·9 claims
- 3858US9751949B2Method of inhibiting adipogenesis with an IL-20 antibodyUNIV NAT CHENG KUNG·Filed 2014·Granted Sep 5, 2017·0 cites·10 claims
- 3957US11661450B2Combination therapy using an IL-20 antagonist and an immune checkpoint inhibitorLBL BIOTECHNOLOGY INC·Filed 2020·Granted May 30, 2023·0 cites·11 claims
- 4055US2013216534A1Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosisUNIV NAT CHENG KUNG·Filed 2013·Application pending·0 cites
- 4154US2004248097A1Interleukin-20 variants and promotersFiled 2003·Application pending·0 cites
- 4253US9512218B2Use of IL-20 antagonists for alleviating spinal cord injuryUNIV NAT CHENG KUNG·Filed 2014·Granted Dec 6, 2016·0 cites·14 claims
- 4351US9982043B2Use of IL-20 antagonists for treating pancreatic cancerUNIV NAT CHENG KUNG·Filed 2016·Granted May 29, 2018·0 cites·6 claims
- 4450US2005147611A1Combination therapy for conditions leading to bone lossAMGEN INC·Filed 2005·Application pending·0 cites
- 4550US2004076606A1Methods of modulating inflammation by administration of interleukin-19 and inhibitors of IL-19 bindingCHANG MING-SHI·Filed 2002·Application pending·0 cites
- 4647US11279755B2Use of IL-20 antagonists for treating eye diseasesLBL BIOTECHNOLOGY INC·Filed 2018·Granted Mar 22, 2022·0 cites·10 claims
- 4747US9376490B2Treatment of inflammatory pain using IL-20 antagonistsUNIV NAT CHENG KUNG·Filed 2014·Granted Jun 28, 2016·0 cites·14 claims
- 4844US2017348389A1Treating liver diseases with interleukin 24UNIV NAT CHENG KUNG·Filed 2016·Application pending·0 cites
- 4944US2014065144A1Use of il-20 antagonists for promoting bone fracture healingCHANG MING-SHI·Filed 2012·Application pending·0 cites
- 5037US2012034224A1Treating Rheumatoid Arthritis with Anti-IL-19 AntibodyCHANG MING-SHI·Filed 2010·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →